Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management
The state-of-the-art facility is expected to be commissioned over the next three years
The company operates a chain of mid-sized multi-speciality hospitals
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
CRL shall invest another Rs. 200 crore for creation of additional beds
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Subscribe To Our Newsletter & Stay Updated
